Evidence of CD4+ regulatory T cells in the non-obese diabetic male mouse
- PMID: 7914880
- DOI: 10.1007/BF00408468
Evidence of CD4+ regulatory T cells in the non-obese diabetic male mouse
Abstract
The NOD mouse, which shows many features of human IDDM, is extensively used to evaluate the role of T lymphocytes in the pathogenesis of autoimmune diabetes. The development of diabetes in this model appears to be controlled by a finely tuned immunoregulatory balance between autoaggressive T cells and regulatory immune phenomena, the disruption of which may result in destruction of insulin-secreting cells. The absolute requirement of sublethal irradiation to permit transfer of the disease to non-diabetic adult syngeneic mice provides indirect evidence for the presence of regulatory T cells in non-diabetic NOD mice. We have previously reported that the reconstitution of irradiated recipients by CD4+ T cells from nondiabetic female NOD mice blocks the transfer of diabetes by spleen cells from diabetic donors. We now report evidence that anti-CD4 monoclonal antibodies can substitute for irradiation in rendering adult NOD male mice susceptible to diabetes transfer by diabetogenic spleen cells. Efficient diabetes transfer can be achieved in non-irradiated adult NOD recipients provided they are thymectomized and CD4+ T-cell depleted prior to the transfer. The role of thymectomy is to limit T cell regeneration after anti-T cell monoclonal antibody challenge. Our data confirm that regulatory CD4+ T-cells, which efficiently counterbalance diabetogenic cells, are present in adult NOD male animals.
Similar articles
-
Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors.Diabetes. 1993 Jan;42(1):44-55. doi: 10.2337/diab.42.1.44. Diabetes. 1993. PMID: 8093606
-
alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10.J Exp Med. 1998 Apr 6;187(7):1047-56. doi: 10.1084/jem.187.7.1047. J Exp Med. 1998. PMID: 9529321 Free PMC article.
-
T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice.J Exp Med. 1989 May 1;169(5):1669-80. doi: 10.1084/jem.169.5.1669. J Exp Med. 1989. PMID: 2523954 Free PMC article.
-
CD3 antibody treatment stimulates the functional capability of regulatory T cells.Novartis Found Symp. 2003;252:279-86; discussion 286-90. Novartis Found Symp. 2003. PMID: 14609225 Review.
-
Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.Ann N Y Acad Sci. 2005 Jun;1051:72-87. doi: 10.1196/annals.1361.048. Ann N Y Acad Sci. 2005. PMID: 16126946 Review.
Cited by
-
Grafts of supplementary thymuses injected with allogeneic pancreatic islets protect nonobese diabetic mice against diabetes.Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):874-7. doi: 10.1073/pnas.012597499. Epub 2002 Jan 15. Proc Natl Acad Sci U S A. 2002. PMID: 11792835 Free PMC article.
-
Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E.Am J Pathol. 1995 Nov;147(5):1193-9. Am J Pathol. 1995. PMID: 7485382 Free PMC article.
-
Implantation of Islets Co-Seeded with Tregs in a Novel Biomaterial Reverses Diabetes in the NOD Mouse Model.Tissue Eng Regen Med. 2025 Jan;22(1):43-55. doi: 10.1007/s13770-024-00685-7. Epub 2024 Dec 30. Tissue Eng Regen Med. 2025. PMID: 39738937 Free PMC article.
-
Unique role of CD4+CD62L+ regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice.Proc Natl Acad Sci U S A. 2004 Oct 5;101 Suppl 2(Suppl 2):14580-5. doi: 10.1073/pnas.0404870101. Epub 2004 Aug 30. Proc Natl Acad Sci U S A. 2004. PMID: 15340148 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials